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Celldiﬀerentiationonglutaraldehydecross-linkedovalbuminscaﬀoldswasthemainfocusofthisresearch.Saltleachingandfreeze
drying were used to create a three-dimensional porous structure. Average pore size was 147.84 ±40.36μm and 111.79 ±30.71μm
for surface and cross sectional area, respectively. Wet compressive strength and elastic modulus were 6.8 ± 3.6kP a.A verageglass
transition temperature was 320.1±1.4
◦C. Scaﬀolds were sterilized with ethylene oxide prior to seeding MC3T3-E1 cells. Cells were
stained with DAPI and Texas red to determine morphology and proliferation. Average cell numbers increased between 4-hour-
and 96-hour-cultured scaﬀolds. Alkaline phosphatase and osteocalcin levels were measured at 3, 7, 14, and 21 days. Diﬀerentiation
studies showed an increase in osteocalcin at 21 days and alkaline phosphatase levels at 14 days, both indicating diﬀerentiation
occurred. This work demonstrated the use of ovalbumin scaﬀolds for a bone tissue engineering application.
1.Introduction
Autogenous bone is the most preferred bone grafting
material.However,limitationsandcomplicationsfromusing
autografts include a limited quantity and chronic donor site
pain [1, 2]. This has led to the need for an ideal bone
graft substitute. An ideal substitute must have enhanced
capabilities to reduce or eliminate the need for an autograft
altogether [3]and are necessary to provide support, ﬁll voids,
and enhance biologic repair of defects.
The need for tissue-engineered constructs is increasing
and advances in the ﬁeld have led to the use of scaﬀolds,
cells, and factors to regenerate organs and tissues [3].
The integration of the biological, physical, and engineering
sciences will create the new constructs that regenerate and
restore the functional state of damaged tissues [4]. Using
tissue engineered constructs such as biobased scaﬀolds as
bone graft substitutes has emerged as an approach to
regenerate bone.
Tissue-engineered constructs, speciﬁcally biopolymers,
can promote successful bone healing when originating from
natural proteins found in the body. Ovalbumin (OA) is
being used in this study because it is a biopolymer found
in chicken egg whites, has a molecular mass of 45kDa,
and is comprised of 386 amino acids with 10% of the
amino acid sequence conserved when compared to human
serum albumin. OA is comprised mainly of α-helix and
β-sheet, but when introduced to an alkaline environment
(pH > 7), it transforms to a predominantly β-sheet structure
[5]. It can be used to create biocompatible scaﬀolds that
aid in osteoblast adhesion and mineralization into 3D
structures [6]. Ovalbumin is more readily available and
cheaper ($40/kg, Sigma Aldrich) than using synthetic or
other natural biopolymers [7].
Ovalbumin contains nineteen lysines per OA molecule
which are necessary for chemical crosslinking with a
common agent, glutaraldehyde (GA) [8]. Glutaraldehyde
crosslinking is governed by reactions with ε-amino groups
of lysines (Figure 1). The GA crosslinking process has been
shown to alter cellular response due to its cytotoxicity [9]
andmayalterosteoblasticresponsesthroughmodiﬁcationof
the scaﬀolds [10]. However, it has been previously reported
that using GA as a crosslinker for other biopolymer scaﬀolds
such as collagen, alginate, and keratin has not aﬀected2 Journal of Tissue Engineering
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Figure 1:(a)Schiﬀbaseformationobtainedbycrosslinkingoflysineresiduesfromtwoprotein(P)moleculesbymonomericglutaraldehyde.
(b) The structure of polymeric glutaraldehyde. (c) Suggested end product obtained from reaction between polymeric glutaraldehyde and
lysine residues from the cross-linked proteins16 .
biocompatibility [11–13]. Therefore, small concentrations of
GAwillbeusedtopreventcytotoxicity,andOAscaﬀoldsmay
also be created using this method.
Both a material and biological perspectives are needed
to fully understand interactions in the body to make
biomaterial scaﬀolds successful. From a material perspective,
the extent of how surface properties and material char-
acteristics aﬀect cell behavior must be determined. It is
also important to know the parameters that govern positive
cell response to a biomaterial and what in vitro models
reproduce these parameters in order to conduct successful
research [14]. Using these results as a guideline, a biobased
scaﬀold for osteoblast adherence and proliferation can be
envisioned. biobased polymers need to be researched for
further tissue engineering advances, speciﬁcally their use
in bone regeneration [15]. This study aims to create a
biobased OA scaﬀold and investigate the eﬀects of adhesion,
growth, and diﬀerentiation of preosteoblast cells on these
structures.
2.MaterialsandMethods
2.1. OA Solution. To create an OA solution, 5.0g OA from
chicken egg white, grade II (Sigma Aldrich) and 0.01g
dithiothreitol (Sigma Aldrich) minimum 99% titration were
dissolved in 30mL borate buﬀer (pH 9.5) and 50mL
deionized (DI) water. The solution was stirred overnight
at room temperature and dialyzed using snake skin dialysis
tubing in water at room temperature for three days. The
waterwaschangedtwiceadayforthedurationofthedialysis.
Thedialyzedsolutionwasthenstoredintherefrigeratoruntil
use.
2.2. Scaﬀold Fabrication. Scaﬀolds were fabricated using
sodium chloride salt porogen, OA solution, and GA (Sigma-
Aldrich, Grade I, 25% in H2O) crosslinker. One gram sieved
salt with particle sizes 90–150μm was measured into wells
of a 12-well plate. Two and a half milliliters dialyzed OA
solution was pipetted over the salt of each well plate. Ten
percent GA to OA solution by volume was pipetted into
the wells to introduce crosslinking. Each well was stirred to
ensure equal distribution and placed on a shaker overnight
to allow for crosslinking.
Once cross-linked, the scaﬀolds were removed from the
well plates and placed in 150mL of 100mM glycine (Sigma
Aldrich)solutionat35◦CtoterminateGAcrosslinking.After
one hour the scaﬀolds were taken out of the glycine solution
and placed in a beaker of DI water to commence the salt
leaching process. The beakers were placed on a shaker and
the scaﬀolds remained in DI water for three days and water
changed twice a day during the process.
Afterthesaltleachingprocessthescaﬀoldswereplacedin
the −80◦C freezer overnight. The next day they were placed
in a lypholizer at −80◦C and 10torr overnight to remove
excess water. After 24 hours the samples were removed and
placed in a desiccator until use.
2.3. Percent Crosslinking. A trinitrobenzenesulfunic acid
(TNBSA) assay as described by Hermanson [16]w a sp e r -
formed to measure the number of ε-amino groups in the
scaﬀolds to determine percent crosslinking. Scaﬀolds with
10% GA to OA solution by volume crosslinking as well
as OA powder (as previously discussed) as a control were
used in the study. Brieﬂy, 11mg dry scaﬀold was placed
in a 50mL screw cap tube with 1mL of 4% NaHCO3 andJournal of Tissue Engineering 3
1mL 0.5% TNBSA. The vial was placed in a water bath
with a stirring bar at 320rpm at 40◦C for four hours. Three
milliliters of 6M HCl was added to the vial to hydrolyze the
reaction and then the vial was placed in the autoclave for
one hour at 120◦C and 15–17psi to hydrolyze and dissolve
the protein. After autoclaving, the solution was diluted with
20mL DI water and read on a UV-vis spectrophotometer at
350nm.
2.4. Scaﬀold Morphology. The surface and cross-sectional
area scaﬀold morphologies were viewed using the FESEM
(Leo/Zeiss 1550, Munich, Germany). Samples were sprayed
with 15μm thick conductive Gold-Palladium coating under
vacuum in an argon atmosphere. Samples were observed in
the FESEM under vacuum at 5kV.
Average pore size was determined by viewing FESEM
images in a Q analysis program and measuring the diameter
of 25 diﬀerent pores. Pores were identiﬁed as areas of void
space.
2.5. Mechanical and Thermal Testing. Scaﬀolds were me-
chanically tested by compression using an Instron 5869
with a 100kN load cell. Compression tests were carried
out on samples with approximately twenty millimeter
diameters and approximately seven millimeter heights at a
crosshead speed of 2mm/minute. Scaﬀolds were submerged
in phosphate buﬀered saline (PBS) solution for two days,
completely wetting the samples to allow for wet compression
testing.
Diﬀerential scanning calorimetry (DSC) thermal mea-
surements were performed on wet scaﬀolds and a noncross-
linked OA ﬁlm as the control with a Netzsch 889 analyzer
from 30◦C to 350◦C at a heating rate of 10◦C/minute under a
helium atmosphere. The temperature was decreased to room
temperature at a rate of 10◦C/minute. Thermal analysis was
carried out using the Proteus Thermal Analysis software.
2.6. In Vitro Evaluation
2.6.1. Proliferation Studies. All scaﬀolds were sterilized with
ethylene oxide prior to cell culture. Scaﬀolds were placed
in 48-well plates containing MC3T3-E1 preosteoblasts sus-
pended in 0.5mL medium (10,000 cells/scaﬀold) for 4 hours
and 96 hours. MC3T3-E1 cells were cultured in expan-
sion medium containing α-minimum essential medium
(MEM) plus 10% fetal bovine serum (FBS) and 1% antibi-
otic/antiomycotic.
Cell staining [17] consisted of ﬁxing the cells for 5
minutes using 0.5% by volume Triton X-100, 4% by volume
formaldehyde and 1mmol/L CaCl2, 2mmol/L MgCl2 in
phosphate buﬀered saline at pH 7.4. The scaﬀolds were then
rinsed and postﬁxed for 20 minutes in the same ﬁxative as
before without Triton X-100. Cells were stained in the dark
for 1 hour with 2μM Sulforhodamine 101 Phalloidin (Texas
Red) and 6μM4  ,6-diamidino-2-phenylindole (DAPI) in
PBS containing 1mM Ca2+ and 2mM Mg2+ After 5 minutes
of air drying, the scaﬀolds were mounted on glass slides with
Vectashield containing DAPI. Cell number was determined
using confocal microscopy.
2.6.2. Diﬀerentiation Studies. To induce osteoblastic diﬀer-
entiation, cells were seeded and cultured for 3, 7, 14, and
21 days on scaﬀolds. Three scaﬀolds and cross-linked ﬁlms
were tested per time period with an empty well as a control.
MC3T3-E1 preosteoblast cells were cultured on ethylene
oxide sterilized 5.5mm diameter scaﬀolds as well as cross-
linked ﬁlms. A 48-well plate with 0.5mL expansion medium
(per well) supplemented with ascorbic acid (50mg/mL)
and β-glycerol phosphate (10mmol/L) to enhance osteoblast
diﬀerentiation was used. The medium was changed every
3 days during the diﬀerentiation studies. To determine if
diﬀerentiation occurred, scaﬀolds were kept for ALP level
analysis using a reagent assay.
OCN levels were measured for each time interval
using an enzyme-linked immunosorbant assay (ELISA)
kit (Biotechnologies, Inc.) according to the manufacturer’s
directions
2.7. Statistics. All experiments were performed with three
scaﬀolds and cross-linked ﬁlms unless otherwise speciﬁed.
The results were reported as mean ± standard deviation.
Statistical signiﬁcance was determined by single factor
analysis of variance (ANOVA) with P<. 05
3. Results
3.1. Percent Crosslinking. Using the TNBSA assay, percent
crosslinking averages for the scaﬀolds were determined.
Moles of lysine present were calculated using average
absorbencies for the scaﬀolds. The percent crosslinking was
calculated by using the average moles of lysine at 350nm
for the OA powder control and 10% GA to OA solution by
volume scaﬀolds. It was determined that the scaﬀolds had a
percentage crosslinking of 35 ± 9%.
3.2. Scaﬀold Morphology. SEM analysis of the scaﬀolds
allowed for morphology and size of pores to be evaluated.
A porous structure was viewed for both surface and cross-
sectional area (CSA) of the scaﬀolds and average pore
size was determined. Average pore size for the surface was
147.84 ± 40.36μm and 111.79 ± 30.71μm for the CSA. No
signiﬁcant diﬀerence was found between the surface and
CSA. Figure 2 shows a representative image for pore size and
morphology of the scaﬀolds.
3.3. Mechanical and Thermal Tests. Scaﬀolds were tested wet
todeterminetheeﬀectonultimatecompressivestrength.The
average ultimate stress and elastic moduli for the scaﬀolds
were 6.8 ± 3.6kPa. Wet scaﬀolds exhibited elastic behavior.
Using the Proteus Thermal Analysis software, the glass
transition temperature (Tg) of the scaﬀolds and OA powder
control were found. The control had a Tg of 240 ± 35◦Ca n d
the scaﬀold, 320.1 ±1.4◦C.
3.4. Cell Studies
3.4.1.ProliferationStudies. Cells were stained with DAPI and
Texas Red to look at cell morphology on the scaﬀolds. Nuclei
were stained blue due to the DAPI binding to the DNA while4 Journal of Tissue Engineering
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Figure 2: FESEM scaﬀold image illustrating scaﬀold morphology
and pore size. Image is taken at 200x.
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Figure 3: Scaﬀolds at 21 days showed a signiﬁcant increase in OCN
levels when compared to the control and 10% cross-linked ﬁlm.
Texas Red binds to the F-actin of cells staining it red. Because
of the scaﬀolds autoﬂuoresce, it was impossible to see the
stainedcellbodytodeterminemorphologyalongthescaﬀold
pores. However, cell numbers for both the 4-hour and 96-
hour time intervals could be determined by counting the
stained nuclei. At four hours the average number of cells on
the scaﬀolds was 60.8 ± 18.9c e l l sp e ri m a g ea n da t9 6h o u r s
the average number of cells was 153 ± 4.8c e l l sp e ri m a g e ,a
twofold increase. Cell numbers between time intervals were
signiﬁcant.
3.4.2. Diﬀerentiation Studies. Diﬀerential studies compared
scaﬀold OCN levels at 3-, 7-, 14-, and 21-day time intervals
to standard solutions. OA powder as a control (as previously
mentioned) and 10% by volume GA to OA solution cross-
linked ﬁlms were also compared to a standard curve
found from the average standard absorbances calculated.
Absorbance for all samples was determined and compared.
Scaﬀolds at 21 days showed a signiﬁcant increase in OCN
levels when compared to the control and cross-linked ﬁlm
(Figure 3).
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Figure 4: A signiﬁcant increase in ALP in the control well was
seen at 7, 14, and 21 days when compared to the control well at
3 days. ALP levels for cross-linked ﬁlms at 14 and 21 days showed
a signiﬁcant increase compared to cross-linked ﬁlms at 3 and 7
days. Scaﬀolds showed a signiﬁcant increase at 14 days compared
to scaﬀolds at 3 and 7 days with a downregulation at 21 days.
A signiﬁcant ALP increase was seen in the control well
at 7, 14, and 21 days when compared to the control well
at 3 days. ALP levels for cross-linked ﬁlms at 14 and 21
days showed a signiﬁcant increase compared to cross-linked
ﬁlms at the 3- and 7-day time intervals. Scaﬀolds showed a
signiﬁcant increase at 14 days when compared to scaﬀolds at
3 and 7 days and a downregulation of ALP production was
seen at 21 days (Figure 4).
4. Discussion
Although GA is a common crosslinking agent, the mecha-
nism and chemistry involved in the crosslinking reaction is
not yet fully understood [18]. It has been shown that varying
GA concentration has an eﬀect on crosslinking [19]. At low
concentrations of GA, it is more probable for GA to crosslink
with lysines in OA molecules because the amount of lysines
is equal to or greater than the amount GA molecules present.
AthigherconcentrationsofGA,itismoreprobableforGAto
reactwithitselfbecausetheamountofGAmoleculesislarger
than the amount of lysines present to crosslink. Therefore,
there is a limit to how much GA is able to crosslink with
lysine molecules. This explains why only 35% crosslinking
was observed in the scaﬀo l d sa n dc o n ﬁ r m st h a ta ne x c e s so f
GA was used.
The average pore size of the scaﬀolds in this study
corresponds with those reported in the literature [20–22]
that have been shown as optimal pore size for cell adhesion,
proliferation, and diﬀerentiation [23]. The wet compressive
mechanical properties of the scaﬀolds fell below the actual
compressive strength of bone. Compact bone is known
to have a compressive strength of 150–250MPa due to
variability in bone density [24, 25]. Although the idealJournal of Tissue Engineering 5
mechanical strength of biomaterial scaﬀolds has not yet
been determined, previously researched scaﬀold compressive
strengths have fallen within a 2–45MPa range [26–28]. The
compressive modulus for bone has been measured to be
5–20GPa while biomaterial scaﬀolds vary from 60MPa–
15GPa [27]. Although OA scaﬀolds are lower in compressive
strength and modulus than other biobased scaﬀolds as well
as natural compact bone, it is not fully understood to
what extent scaﬀolds must mimic natural bone mechanical
properties. They have, however, demonstrated to be a
promising substrate for cell growth and bone regeneration as
shown by the cellular studies and sponge-like characteristics
of the scaﬀolds.
Only glass transition temperatures were observed in the
control and scaﬀold; therefore, it can be concluded that the
scaﬀolds were amorphous. The glass transition temperature
of the control was determined to be 240◦C; so an increase
in Tg to 320◦C for the scaﬀolds conﬁrms crosslinking
occurred.
Using confocal images, cell numbers for the scaﬀolds
at 4 hours and 96 hours were determined and a signif-
icant increase between the 4-hour- and 96-hour-cultured
scaﬀolds was seen. Because of this signiﬁcant increase,
it was determined that the preosteoblast cells responded
positively to the scaﬀold and surrounding environment and
reached a proliferative state. Alkaline phosphatase studies
showed a signiﬁcant increase in cross-linked ﬁlms at 14
and 21 days in comparison to cross-linked ﬁlms at 3 and
7 days. For the scaﬀolds, a signiﬁcant increase in ALP was
seen at 14 days; however a decrease in ALP production
w a ss e e na t2 1d a y s .O s t e o c a l c i nd i ﬀerentiation studies
showed an increase in OCN levels in scaﬀolds cultured
for 3, 7, and 14 days when compared to the control well
and cross-linked ﬁlms; however no signiﬁcant diﬀerence
was found. There was a signiﬁcant increase in OCN levels
in the scaﬀolds cultured for 21 days when compared to
the cross-linked ﬁlm and control well at the same time
interval. It has been shown that at two weeks in vitro,A L P
is increased and then downregulated when mineralization
begins. This corresponds with the scaﬀold OCN data
showing a signiﬁcant increase of OCN at 21 days indicating
the beginning of mineralization. The signiﬁcant increase
in OCN levels at 21 days and the downregulation of ALP
after the two-week time period indicate that diﬀerentiation
occurred.
5. Conclusion
After scaﬀold fabrication, morphology and pore size were
determined and all scaﬀolds had a CSA and surface porous
structure comparative to porous scaﬀolds used in previ-
ously reported literature. Glutaraldahyde was used as the
crosslinker to create the 3D porous structure and material
characterization was conducted on the scaﬀolds. A TNBSA
assay was conducted to determine percent crosslinking of
the scaﬀolds, and it was determined that GA crosslinking
reaction did occur. However, 100% crosslinking was not
reached due to GA intermolecularly crosslinking with itself,
not allowing for chemical interaction with all lysines present
in OA molecules. Also, an average glass transition tempera-
ture, compressive strength, and compressive modulus were
found for the scaﬀolds. Although the average compressive
strength and modulus is lower than bone, the needed
compressivestrengthforscaﬀoldsisnotknownandtherefore
the scaﬀolds cannot be ruled out as a possible substrate
for cell growth and diﬀerentiation. In fact it was shown
through cell studies that despite low compressive strength
and modulus, MC3T3-E1 preosteoblast cells did increase
in number and therefore a proliferative state of the cells
was reached. Diﬀerentiation studies showed a signiﬁcant
increase in OCN levels at 21 days for scaﬀolds. A signiﬁcant
increase in ALP at 14 days was seen for the scaﬀolds as well
as a decrease at 21 days corresponding with the increase
in OCN at 21 days. These results signify the beginning of
mineralization and support the idea that diﬀerentiation did
occur. Overall OA scaﬀolds have shown to be a promising
3D material construct to induce the proliferation and dif-
ferentiation of MC3T3-E1 preosteoblast cells for bone tissue
regeneration.
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